Menu
GeneBe

SLFN14

schlafen family member 14, the group of Schlafen family

Basic information

Region (hg38): 17:35543984-35560819

Links

ENSG00000236320NCBI:342618OMIM:614958HGNC:32689Uniprot:P0C7P3AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • platelet-type bleeding disorder 20 (Strong), mode of inheritance: AD
  • platelet-type bleeding disorder 20 (Supportive), mode of inheritance: AD
  • platelet-type bleeding disorder 20 (Moderate), mode of inheritance: AD
  • platelet-type bleeding disorder 20 (Moderate), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Bleeding disorder, platelet-type, 20ARHematologicIndividuals have increased bleeding tendency, and awareness may allow preventive measures and early management of bleeding complicationsHematologic26280575; 26769223

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the SLFN14 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the SLFN14 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
6
clinvar
5
clinvar
11
missense
1
clinvar
55
clinvar
6
clinvar
8
clinvar
70
nonsense
2
clinvar
2
start loss
0
frameshift
2
clinvar
2
inframe indel
0
splice donor/acceptor (+/-2bp)
1
clinvar
1
splice region
0
non coding
8
clinvar
8
Total 0 1 60 12 21

Variants in SLFN14

This is a list of pathogenic ClinVar variants found in the SLFN14 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
17-35548243-T-A Platelet-type bleeding disorder 20 Benign (Jul 15, 2021)1245977
17-35548254-C-T SLFN14-related disorder Benign/Likely benign (May 24, 2019)738205
17-35548265-G-A Platelet-type bleeding disorder 20 Benign (Jul 15, 2021)1239057
17-35548286-C-G Uncertain significance (Nov 06, 2017)453121
17-35548292-A-G Abnormal bleeding;Thrombocytopenia Uncertain significance (May 01, 2020)988812
17-35548340-TA-T Platelet-type bleeding disorder 20 Uncertain significance (Sep 03, 2021)1803221
17-35548353-G-A Inborn genetic diseases Likely benign (Feb 06, 2024)3165971
17-35548402-T-C Inborn genetic diseases Uncertain significance (May 21, 2024)3320451
17-35548418-C-T Inborn genetic diseases Uncertain significance (Mar 02, 2023)2466395
17-35548426-G-A Uncertain significance (Nov 12, 2019)1310115
17-35548435-A-C Inborn genetic diseases Uncertain significance (Jun 10, 2024)3320458
17-35548506-G-T Inborn genetic diseases Conflicting classifications of pathogenicity (Dec 01, 2022)756570
17-35548523-A-G Inborn genetic diseases Uncertain significance (Aug 08, 2022)2305913
17-35548559-G-T not specified • Inborn genetic diseases Uncertain significance (Jul 05, 2022)1337507
17-35548669-T-A SLFN14-related disorder Likely benign (Dec 11, 2023)3038068
17-35548687-A-G Inborn genetic diseases Uncertain significance (Feb 12, 2024)3165970
17-35548717-G-A Inborn genetic diseases Uncertain significance (Jan 24, 2024)3165969
17-35548762-G-A Inborn genetic diseases Uncertain significance (Nov 23, 2021)2254545
17-35548771-A-G Inborn genetic diseases Uncertain significance (Jul 09, 2021)2229409
17-35548778-A-C Inborn genetic diseases Uncertain significance (Apr 20, 2024)3320453
17-35548791-G-C SLFN14-related disorder Benign/Likely benign (Jan 24, 2020)751826
17-35548804-C-T Inborn genetic diseases Uncertain significance (Jul 12, 2022)2300854
17-35548824-AG-A Platelet-type bleeding disorder 20 Uncertain significance (Aug 10, 2018)1033310
17-35548832-G-A Platelet-type bleeding disorder 20 Uncertain significance (Aug 10, 2018)1033309
17-35548847-C-A Inborn genetic diseases Uncertain significance (Jun 07, 2024)3320457

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
SLFN14protein_codingprotein_codingENST00000415846 49974
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
3.51e-90.92900000.00
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense2.433184650.6840.00002256013
Missense in Polyphen89137.810.645811859
Synonymous2.201341700.7860.000008381732
Loss of Function1.901829.10.6190.00000152403

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.000.00
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Protein SLFN14: Shows no ribosome-associated and endoribonuclease activities. {ECO:0000269|PubMed:25996083}.;

Intolerance Scores

loftool
rvis_EVS
2.71
rvis_percentile_EVS
98.93

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.310

Gene Damage Prediction

AllRecessiveDominant
MendelianHighMediumHigh
Primary ImmunodeficiencyHighHighHigh
CancerHighHighHigh

Mouse Genome Informatics

Gene name
Slfn14
Phenotype

Gene ontology

Biological process
mRNA catabolic process;rRNA catabolic process;platelet maturation;cellular response to magnesium ion;cellular response to manganese ion;RNA phosphodiester bond hydrolysis, endonucleolytic
Cellular component
nucleus;cytoplasm
Molecular function
endoribonuclease activity;ATP binding;ribosome binding